Trump slashes Medicare drug subsidies, cutting against affordability message

The end of a subsidy program that helped keep costs down for Medicare drug coverage could leave millions of seniors with higher monthly costs, a move that undermines the Trump administration’s message of cutting drug costs. President Trump often touts his push for access to cheaper drugs through the TrumpRx platform an

The program, established in 2021, has grown from 170 to nearly 700 recipients. A recent report raised concerns about the program’s financial sustainability.

A Medicare Drug Subsidy Is Ending—Here’s What Patients Should Know  Forbes

The Trump administration is ending a Medicare drug subsidy program. Here’s how it could affect costs.  Chicago Tribune

Millions of older adults on Medicare prescription drug coverage could face higher monthly costs in 2027

The Trump administration is ending a Medicare drug subsidy program. Here's how it could affect costs  AP News

Decision to eliminate concession could mean higher monthly insurance premiums for millions of people

To get prescription drugs in America, you often have to spend an egregious amount for each refill, especially if you don’t have health insurance. Medicare Part D, also known as Medicare drug coverage, aimed to help solve that issue.  However, the Trump administration announced this week that it will be ending a subsidy

Trump administration will end the Medicare Part D subsidy after 2026, raising concerns over higher drug plan premiums for millions of seniors in 2027.

The prescription drug benefit is used by millions of seniors.

The Trump administration intends to end a subsidy program that helped lower costs for Medicare drug plans, a move that could potentially raise monthly costs for older adults.

Exclusive | Trump Administration to End Medicare Drug Plan Subsidy  WSJ